Q4'23 results due 2 February. 23e EBITDA cut 1.4% and down 11.5% & 12.8% for '24e & '25e. 38-45% below historical multiples, but above sector peers.

15 Jan 2024
Genetic services holding back growth again

Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Genetic services holding back growth again
- Published:
15 Jan 2024 -
Author:
ABGSC Healthcare Research | Sten Gustafsson -
Pages:
13 -
Q4'23 results due 2 February. 23e EBITDA cut 1.4% and down 11.5% & 12.8% for '24e & '25e. 38-45% below historical multiples, but above sector peers.